| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |